Official Title
Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study
Brief Summary

A number of clinical features suggest the possibility of dysautonomia in patients infected with SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). At the same time, there is now strong experimental evidence that SARS-CoV-2 can cross the blood-brain barrier, probably via the olfactory nerves, and reach the brain stem, which is located in close proximity. Damage to the brainstem nuclei could explain the suspected dysautonomic episodes, but also the severity of respiratory distress in infected patients, and the difficulty of ventilatory withdrawal encountered in resuscitation, potentially through damage to the ventilation control and regulation centers located in the brainstem. The objective of this study is to record the long term variability in heart rate, reflecting autonomic balance, of patients screened positive for SARS-CoV-2 throughout their stay in conventional care units at the Saint-Etienne University Hospital, in order to see whether there is an autonomic imbalance at screening, whether the worsening of the autonomic imbalance precedes the worsening of the clinical condition, and how quickly the expected correction of the autonomic imbalance follows or precedes that of the disease.

Detailed Description

In this study, patients will have a continuous recording of their heart rhythm via a
holter-ECG throughout their hospitalization.

Completed
SARS-CoV 2

Other: ECG-Holter

Patient will have a ECG-Holter recording during all their hospitalization.

Eligibility Criteria

Inclusion Criteria:

- major

- with clinical signs of SARS-CoV-2

- understanding and speaking French fluently to understand the explanations and
participate in the study

- who have given their oral consent to participate in the study

- affiliated or entitled to a social security scheme.

Exclusion Criteria:

- with a history of Parkinson's disease, insulin-dependent or non-insulin-dependent
diabetes at a dysautonomic stage or chronic alcoholism at a dysautonomic stage

- with atrial fibrillation on the ECG trace taken at the time of their entry.

- refusing to participate in the study

- intubated prior to inclusion in the study

- that are within the exclusion period of another research protocol

- with a history of head injury, neurological pathology with a brain impact, or serious
unstable somatic disease

- patient under guardianship.

- pregnancy woman

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

CHU Hopital nord
Saint-Étienne, France

David CHARIER, MD, Principal Investigator
CHU SAINT-ETIENNE

Centre Hospitalier Universitaire de Saint Etienne
NCT Number
Keywords
Covid-19
SARS-CoV-2
Coronavirus
Dysautonomia
MeSH Terms
COVID-19
Primary Dysautonomias
Autonomic Nervous System Diseases